rL-RVG抑制人小细胞肺癌细胞系NCI-H446的增殖及迁移

doi:10.16352/j.issn.1001-6325.2022.10.1549

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (10): 1549-1554.doi: 10.16352/j.issn.1001-6325.2022.10.1549

rL-RVG抑制人小细胞肺癌细胞系NCI-H446的增殖及迁移

梁冰¹, 严玉兰^2*

1.昆山市中医医院呼吸科,江苏昆山 215300;
2.江苏大学附属人民医院呼吸科,江苏镇江 212000

收稿日期:2021-05-28 修回日期:2022-01-07 出版日期:2022-10-05 发布日期:2022-09-23
通讯作者: * ylyan2005@163.com
基金资助:
苏州市科技发展计划(民生科技)(SYS2020066);昆山市社会发展项目(KS1653)

rL-RVG inhibits the proliferation and migration of human small cell lung cancer cell line NCI-H446

LIANG Bing¹, YAN Yu-lan^2*

1. Department of Respiratory Medicine, Kunshan Hospital of Traditional Chinese Medicine, Kunshan 215300;
2. Department of Respiratory Medicine, the Affiliated People's Hospital of Jiangsu University, Zhenjiang 212000, China

Received:2021-05-28 Revised:2022-01-07 Online:2022-10-05 Published:2022-09-23
Contact: * ylyan2005@163.com

摘要/Abstract

摘要： 目的探讨重组新城疫病毒rL-RVG对人小细胞肺癌细胞系NCI-H446增殖、迁移的影响及可能的作用机制。方法将NCI-H446细胞随机分为3组,分别加入PBS、新城疫病毒(NDV)和rL-RVG,PBS为对照组。用免疫荧光法检测RVG及NDV蛋白在细胞内的表达;用MTT法测定病毒的抗增殖情况;划痕实验及Transwell小室法检测细胞迁移情况;免疫荧光法检测相关迁移蛋白E-cadherin和MMP2的表达。结果 rL-RVG在NCI-H446细胞中的感染率高,并能够在其内稳定表达;rL-RVG对小细胞肺癌细胞的抑制效果强于NDV。rL-RVG组划痕距离显著小于NDV组及对照组(P＜ 0.05);rL-RVG组穿过小室的细胞数明显少于对照组(P＜ 0.05)。相较于NDV及对照组,rL-RVG组的MMP2蛋白表达下降,而E-cadherin蛋白表达上调。结论 rL-RVG能够抑制NCI-H446细胞增殖,其机制可能是通过调节E-cadherin和MMP2而影响细胞迁移。

关键词: 小细胞肺癌, 新城疫病毒, 迁移

Abstract: Objective To investigate the effect and potential mechanism of recombinant Newcastle disease virus rL-RVG on proliferation and migration of human small cell lung cancer cell line NCI-H446. Methods NCI-H446 cells were divided into 3 groups: incubated with PBS, Newcastle disease virus(NDV) and rL-RVG, respectively. Immunofluorescence assay was used to detect the expression of RVG and NDV protein. MTT assay was used to determine the anti-proliferation of the virus. The cell migration was detected by scratch test and Transwell method. Immuno-fluorescence assay was used to detect the expression of E-cadherin and MMP2 proteins. Results After infection, rL-RVG stably expressed in NCI-H446 cell with high infection efficiency.The scratch distance in rL-RVG group was significantly shorter than that in NDV group and control group(P＜0.05). In the Transwell experiment, the number of cells crossing the compartment in the rL-RVG group were significantly less than that in the control group(P＜0.05). MMP2 protein expression was down-regulated in rL-RVG group, while E-cadherin protein expression was up-regulated(P＜0.05), compared with NDV group and control group. Conclusions rL-RVG could inhibit the proliferation of NCI-H446 cell with the potential mechanism of effects on cell migration through regulating E-cadherin and MMP2.

Key words: small cell lung cancer, Newcastle disease virus, migration

中图分类号:

梁冰, 严玉兰. rL-RVG抑制人小细胞肺癌细胞系NCI-H446的增殖及迁移[J]. 基础医学与临床, 2022, 42(10): 1549-1554.

LIANG Bing, YAN Yu-lan. rL-RVG inhibits the proliferation and migration of human small cell lung cancer cell line NCI-H446[J]. Basic & Clinical Medicine, 2022, 42(10): 1549-1554.

参考文献 11

[1]	徐婷婷,韩继武. 新城疫病毒抗恶性肿瘤研究进展[J]. 医学综述, 2019, 25: 1123-1127.
[2]	Vähä-Koskela MJ, Heikkilä JE, Hinkkanen AE. Oncoly-tic viruses in cancer therapy[J]. Cance Lett, 2007, 254:178-216.
[3]	Ge J, Wang X, Tao L, et al. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats[J]. J Virol, 2011, 85: 8241-8252.
[4]	严玉兰,梁冰,张金,等. rL-RVG体外抑制肺癌细胞增殖并促进其凋亡[J]. 细胞与分子免疫学杂志, 2014, 30: 449-452, 457.
[5]	金惠,步雪峰,王穆彬,等. 重组新城疫病毒rL-RVG抑制人肺腺癌A549系细胞迁移及相关机制[J]. 基础医学与临床, 2015, 35: 508-513.
[6]	Sinkovics JG, Horvath JC. Newcastle disease virus(NDV):brief history of its oncolytic strains[J]. J Clin Virol, 2000, 16: 1-15.
[7]	Sahai E. Mechanisms of cancer cell invasion[J].Curr Opin Genet Dev, 2005, 15: 87-96.
[8]	金惠. 表达狂犬病毒糖蛋白的重组新城疫病毒抑制肺腺癌细胞株迁移活性研究[D]. 镇江: 江苏大学, 2015: 1-62.
[9]	尹超云,张垚,陈振威,等. 重组新城疫病毒IL29抑制人胃癌细胞系BGC的增殖与迁移[J].基础医学与临床, 2020, 3: 368-373.
[10]	孙春凤. 基质金属蛋白酶-2的结构和功能[J]. 安徽医科大学学报, 2013, 48: 330-332, 封3.
[11]	Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer--TIMP-1 as a prognostic marker[J].Anticancer Res, 2000, 20:1311-1316.

[1]	郑红, 陈晓霞, 韩李周, 陈苗, 皇甫娟. 降低lncRNA-RMRP表达抑制人肺癌细胞系A549的增殖和侵袭[J]. 基础医学与临床, 2024, 44(7): 974-978.
[2]	曹清文, 祁琳, 禹博, 田晨晨, 袁海宁, 王越. 红景天苷促进人血管内皮细胞系EA.hy926增殖与迁移[J]. 基础医学与临床, 2024, 44(7): 925-930.
[3]	贾安娜, 郭金鑫, 张璇, 战世佳, 于永波, 郭永丽, 常艳. TMEFF1对神经母细胞瘤细胞系增殖的调控[J]. 基础医学与临床, 2024, 44(5): 637-644.
[4]	宋可, 宋柯, 李静宇, 马伟, 杨晓葵. 小鼠卵母细胞减数分裂中心粒蛋白SAS-6的表达和亚细胞分布[J]. 基础医学与临床, 2024, 44(5): 651-657.
[5]	梁香存, 魏小雨, 梁健, 王庆, 耿广. 安罗替尼通过调控miR-16-5p/PD-1轴抑制人非小细胞肺癌细胞系增殖并促进凋亡[J]. 基础医学与临床, 2024, 44(4): 503-512.
[6]	陆凯, 陆建菊, 郭文利, 黄建棋, 李志华. lncRNA VIM-AS5在人乳腺癌细胞系中的表达及对乳腺癌细胞增殖和迁移的影响[J]. 基础医学与临床, 2024, 44(4): 447-453.
[7]	张婧, 杨自更, 蔡文琴, 曹维维, 韦红梅, 薛茜茜, 吴宾. 抑制抗增殖蛋白2增强非小细胞肺癌细胞系A549对厄洛替尼敏感性[J]. 基础医学与临床, 2024, 44(3): 325-332.
[8]	李娟, 李晓峰, 徐生志, 唐凯. 华蟾素胶囊联合多西紫杉醇+顺铂化疗用于非小细胞肺癌患者的疗效[J]. 基础医学与临床, 2024, 44(2): 247-251.
[9]	方媛, 李轶, 王玮. CircRERE调节miR-128-3p/WEE1轴促进人多发性骨髓瘤细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2024, 44(2): 210-218.
[10]	丁飞, 王洒, 黄常新. 非小细胞肺癌患者血清CA211水平和NK细胞数与预后相关[J]. 基础医学与临床, 2024, 44(2): 180-184.
[11]	张伟, 张振, 杨连任, 梁伟. 肺癌7项抗体水平与NSCLC患者化疗效果及预后的关系[J]. 基础医学与临床, 2024, 44(10): 1383-1387.
[12]	王春燕, 王萍, 宋龙飞, 刘永全, 满君. LncRNA FEZF1-AS1通过调控EZH2对肺间质细胞增殖、迁移及侵袭的作用[J]. 基础医学与临床, 2024, 44(1): 43-50.
[13]	苏拾香, 王语阳, 覃宗帅, 黄桂香, 徐键, 岑兰英, 覃月秋. miR-142-3p通过调控Hmgb1抑制雨蛙素诱导的大鼠胰腺外分泌细胞系AR42J凋亡[J]. 基础医学与临床, 2024, 44(1): 23-30.
[14]	颜晨红, 金儿. 外泌体PD-L1在非小细胞肺癌诊断和治疗上的研究进展[J]. 基础医学与临床, 2023, 43(9): 1457-1461.
[15]	张小婉, 康霞, 姚小英, 谢芳, 李莹. 沉默SF3B1促进人肺癌细胞系A549凋亡并抑制其增殖及侵袭[J]. 基础医学与临床, 2023, 43(8): 1265-1270.

rL-RVG抑制人小细胞肺癌细胞系NCI-H446的增殖及迁移

rL-RVG inhibits the proliferation and migration of human small cell lung cancer cell line NCI-H446

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 11

相关文章 15

编辑推荐

Metrics

本文评价